Through the re-appointment of Director He Hongneng as the biotechnology development consultant of the Company, the case concerning the remuneration of Director He should be paid.
The case against The Directors who should be paid by renewing the appointment of Director Ho Hongneng as the Company's health and technology development consultant.
Through the recruitment of director he Hongneng to serve as the company's biotechnology development consultant, the case concerning the salary and remuneration of director he should be paid was proposed.<br>